Merck, GERPN202, Anti-Brdu Antibody

General description
The Anti-Bromodeoxyuridine Antibody is supplied in the same formulation as the monoclonal antibody to BrdU in the kit. The antibody/nuclease mixture is compatible with detection systems that incorporate fluorescently labeled antibodies and biotin-streptavidin detection reagents.
Features and Benefits

• The monoclonal antibody to Bromo-deoxyuridine is supplied in the.same formulation used in the Cytiva Cell Proliferation Kit (RPN20).
• No need for chemical denaturation.
• Detection while maintaining cell morphology.
• Double immunocytochemical staining studies can be perfromed.

Preparation Note
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.